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1. Introduction
Melasma is a common cosmetic problem in our community [1], with social and psychological
burden. It is a disorder of pigmentary system characterized by irregular brown or grayish-
brown, acquired hypermelanosis of sun-exposed areas especially the face [2]. Many prepara‐
tions were used for treatment of melasma, but none of them was ideal [3].
Researchers recently are more involved in performing a research that evaluated the therapeutic
effects of formulation that with active substance of plant origin [4]
Recently, topical polyherbal formulations are the latest additions to the treatment approaches
list of melasma, with a reducing and diverting the production of melanin [5]. The therapeutic
effect of such preparation was enhanced when cosmetic emulsion contained antioxidants are
used as active ingredients [6]. Natural herbs are a rich source of many antioxidatively acting
compounds [7]. Glycyrrhiza glabra is a medicinal plant with rich natural antioxidants [8].The
best natural antioxidants in extract of Glycyrrhiza glabra are glycyrrhizin (glycyrrhizic acid) and
flavonoids [9]. The role of plant extract of Glycyrrhiza glabra on skin is mainly attributed to its
antioxidant activity particularly to its potent antioxidants triterpene, saponins and flavonoids
[10]. G. glabra extract are with therapeutic effects in skin whitening [11], skin depigmenting
[12], skin lightening [3], antiaging [14], anti-erythemic [14], emollient [15], anti-acne [16] and
photoprotection effects [17,18]. A 2.5% G. glabra extract cream was formulated and it was with
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sound chemical and physical stability [19]. In this study, 2.5% of G. glabra extract was
evaluated as treatment of melasma in female.
2. Materials and methods
2.1. Study design
Double blind placebo controlled study. The study population stratified to active or placebo
treatment randomly. The female with even code number receiving cream with active ingre‐
dient while female with odd code number receiving placebo. The cream distributed by a
pharmacist, while the clinical evaluation was performed by a dermatologist clinician.
2.2. Study population
Hundred female volunteers were enrolled in this study between the ages of 20 and 45 years.
They were recruited from Dermatology Clinic in Samarra Teaching Hospital and daily
dermatology clinics. Prior to the tests, the volunteers were examined for any serious skin
disease or damage especially on cheeks and forearms. Before the study, every volunteer was
provided with a volunteer protocol. This protocol stating the terms and conditions of the
testing were to be signed by every volunteer individually. Blood samples were collected from
the 100 volunteer females suffering from melasma.They were diagnosed by consultant
dermatologists. Wood’s lamp (340-400) nm was used to identify the types of melasma whether
epidermal, dermal or mixed (dermoepidermal). Of the total 76%were married and 24% were
single. Serum of the patients and controls were investigated for levels of TSH, estrogen,
progesterone, prolactin, ALT (SGPT), AST (SGOT), total protein, blood urea and S. albumin
before and after treatment.
The history as well as personal information about patients was obtained by questionnaire.
Volunteers were not informed about the contents of formulations. All the skin tests have been
done at 25°C. Erythema of the skin are determined on the first day before application of any
cream and then on days 7, 14, 21 and 28 after treatment. Fifty female from patients group
received the treatment for 28 days, 7 patients were lost to follow up. The above parameters for
forty three patients were determined after treatment. As well as fifty female suffering from
melasma took the placebo, the same above parameters were measured before and after
treatment.
None of the patients or control subjects was on any oral and/or local medication. The pregnant
and lactating females or patients on any hormonal therapy (contraceptive pills) were excluded
from the study. Patients with other systemic diseases like diabetes, hypertension, or on drugs
for any underlying disease were also excluded.
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2.3. Formulation
Water in oil (W/O) active cream (2.5% G. glabra) and base were prepared as described
previously [19].
3. Results
3.1. Age and marital status
A 100 female suffering from melasma, 93 completed the study while 7 patients were lost to
follow up. The distribution of these two groups is shown in Table (1). They were divided into
3 age groups. The highest percentages (50%) and (56%) were found in the age group of (30-39)
years for active cream and control patient groups respectively. The lowest percentage of
incidence for active treatment females was (12%) in the age group of (40-50) years, and for
control, the lowest percentage was (4%) in the age group of (40-50) years. The highest incidence
of melasma was found in married women than in singles of both groups, Table (1).
Formulation Placebo
Age group Married(%)
Single
(%)
Total
(%)
Married
(%)
Single
(%)
Total
(%)
(20-30) 13(26%)
6
(12%)
19
(38%)
16
(32%)
4
(8%)
20
(40%)
(30-40) 22(44%)
3
(6%)
25
(50%)
20
(40%)
8
(16%)
28
(56%)
(40-50) 6(12%)
0
(0%)
6
(12%)
2
(4%)
0
(0%)
2
(4%)
Total 41(82%)
9
(18%)
50
(100%)
38
(76%)
12
(24%)
50
(100%)
Table 1. Distribution of melasma percentage in females according to age and marital status.
3.2. Clinical response
Comparison between formulation treated group and placebo treated group indicated a
significant differences for overall response to treatment. The improvement in active treatment
group was 93% (40/43), while the corresponding value in placebo treated group was 4% (2/50),
(P=0.001). Table 2. The effect of the formulated cream was demonstrated from the 1st week of
treatment course (6.9%), with subsequent increase in improvement rate for week 2 (20.9%),
week 3 (30.2%) and week 4 (34.8%)(P=0.007).
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Variable
Number improved [%]
P value
Formulation
[43 Patient]
Placebo
[50 subject]
Weekly
improved
Cumulative
improvement
Weekly
improved
Cumulative
improvement
Treatment
period
Week 1 3 [6.9] 3 [6.9] 0 [0] 0 [0] 0.18
Week 2 9 [20.9] 12 [27.9] 1 [2] 1 [2] 0.009
Week 3 13 [30.2] 25 [58.13] 1 [2] 2 [4] 0.005
Week 4 15 [34.8] 40 [93.00] 0 [0] 2 [4] 0.001
P value 0.007 0.58
Total response [%] 40 [93] 2 [4]
0.001
No response [%] 3 [6.9] 48 [96]
Table 2. Clinical results of studied and control females with melasma after treatment with the product.
Comparison between the active treated cream and placebo on week interval indicated anon
significant improvement for the first week of the treatment course (P=0.18). However, there
was a significant difference in the improvement rate between the two treatment groups for
week 2 (P=0.009), week 3 (P=0.005) and week 4 (P=0.001), Table 2.
4. Discussion
This clinical trial indicated that 2.5% G. glabra cream was effective as treatment for melasma
in a 28 days course with minimal side effects. However, this finding needs to be strengthening
in a large scale clinical trial. Licorice is an extract with an important depigmenting property,
obtained from Glycyrrhiza glabra. Known as “alcacus”, it contains many compounds, of which
saponins and flavonoids have the greatest antiphlogistic action [20]. In mouse cell culture, it
was observed that Licorice has glabridine, the main component of the hydrophobic fraction of
the extract, with the ability to inhibit tyrosinase without affecting DNA synthesis. The in
vivo results were compatible with those in vitro, and immunohistochemical analysis showed a
reduction of DOPA-positive melanocytes [21]. Moreover, Licorice has anti-inflammatory
action by inhibiting some enzymes of the arachidonic acid cascade, especially cyclooxigenase,
released after exposure to UV rays [22]. Due to these properties, glabridine is an important
depigmenting component of the extract.
Nonetheless, Licorice has other components with depigmenting effects, such as liquiritin,
which disperses melanin. In addition, Licorice has other active ingredient which exert
antioxidant activity and thus Licorice cosmetic properties are attributed to its wide spectrum
of antioxidant activity [23].Ultraviolet radiation in the skin leads to the formation of peroxides
that induce the development of free radicals [24]. Certain licorice constituents possess
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significant antioxidant properties. Glycyrrhizin and glabridin inhibit the generation of reactive
oxygen species (ROS) by neutrophils at the site of inflammation [6].
Traditionally, the use of depigmenting topical substances is without a doubt the best thera‐
peutic option for the clinical treatment of melasma. Hydroquinone, although having some
disadvantages, is the most used therapeutic alternative. [25,26] Nonetheless, many other
substances, mostly of plant origin, have become more popular in dermatologic treatment [27].
In this study, the use of 2.5% G. glabra extract cream shows a reduction in melasma depending
on digital evaluation and size of the lesion.
This study strengthens the clinical benefits of the G. glabra extract substances in the literature
due to their melanin-dependent action (inhibiting tyrosinase, depleting or preventing the
migration of melanosomes) and/or free radical-dependent action (melanogenic inhibition by
preventing radical action on the melanocytes). The active group showed a reduction in the
absolute number of lesions, according to the results obtained by digital photographic imaging,
with significant statistical differences between the active and placebo group.
The adverse effects observed in both groups (Active and placebo) were well tolerated,
spontaneously regressing with the use of the products. We observed, however, that these
effects were less noticed in women using our formulation as only one lady developed allergic
contact dermatitis. However, the side effect in the present study was less than that reported
in subjects using hydroquinone (2%) [28]. Such data suggest the higher safety of G. glabra
extract at 2.5% concentration product used by our patients as compared with hydroquinone,
whose degree of tolerance has already been questioned in the literature [26,29].
The superiority of this greater depigmenting tendency could be better assessed in a prospective
clinical study with a higher number of volunteers. Thus this study indicates that, depending
on the concentrations used, plant extracts can be as efficient as hydroquinone in the treatment
of melasma, without the side effect of hydroquinone. This confirms the viability of future
competitive clinical studies to accurately elucidate a possible clinical superiority and ratify a
tendency of higher tolerability of this new depigmenting alternative. In addition, combination
of G. glabra extract with sun screen in a single formulated is recommended.
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